Announcement of TTY Biopharm's unaudited income information in November 2020
2020.12.10
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2020/12/10 | Time of announcement | 14:30:24 |
| Subject | Announcement of TTY Biopharm's unaudited income information in November 2020 | ||||
| Date of events | 2020/12/10 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2020/12/10 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $313,221 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $45,971 thousands, and a consolidated income before tax of $50,423 thousands in November 2020; net income attributed to stockholders of the company was $39,167 thousands; EPS is $0.16. Year-to-date consolidated net sales was $3,848,819 thousands (in NT dollars; unaudited), a consolidated operating profit was $878,667 thousands and consolidated income before tax was $1,041,379 thousands until November 2020; year-to-date net income attributed to stockholders of the company was $783,778 thousands; EPS is $3.15. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||